PACS Group, Inc. reported $5.55B of revenue over the trailing twelve months, +15% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $5.55B (to Q2 2026). Net income: $269M, trailing twelve months to Q2 2026. Free cash flow: $456M, trailing twelve months to Q2 2026. Operating margin: 7.4%, trailing twelve months to Q2 2026.

PACSPACS Group, Inc.

Healthcare

$43.31+262% 1Y

$43.31

$10.5852 weeks$48.48

PACS as reported

PACS Group, Inc. reported $5.55B of revenue over the trailing twelve months, +15% on the year before. 11 reported series are charted on this page, each one as filed.

$5.55B

Revenue, trailing twelve months · to Q2 2026 · +15% against the twelve months before

Net income: $269M
Net income · +104% year on year · trailing twelve months to Q2 2026
Free cash flow: $456M
Free cash flow · +14% year on year · trailing twelve months to Q2 2026
Operating margin: 7.4%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for PACS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$5.55B	+15%	Q2 2026
Net income	$269M	+104%	Q2 2026
EPS	$1.71	+106%	Q2 2026
Gross margin	23%	n/a	Q2 2026
Operating margin	7.4%	n/a	Q2 2026
Net margin	4.8%	n/a	Q2 2026
ROE	22%	n/a	Q2 2026
ROA	3.9%	n/a	Q2 2026
ROIC	27%	n/a	Q2 2026
Free cash flow	$456M	+14%	Q2 2026
P/E	25.3	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.